These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1706917)

  • 21. Anticoagulant and antithrombotic actions of recombinant hirudin.
    Kaiser B
    Semin Thromb Hemost; 1991 Apr; 17(2):130-6. PubMed ID: 1837615
    [No Abstract]   [Full Text] [Related]  

  • 22. [The pharmacology of recombinant hirudin].
    Kaiser B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):841-9. PubMed ID: 2483701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.
    Esumi N; Fan D; Fidler IJ
    Cancer Res; 1991 Sep; 51(17):4549-56. PubMed ID: 1873799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats.
    Komatsu Y; Hayashi H
    Peptides; 1999 Dec; 20(12):1401-9. PubMed ID: 10698114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
    Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
    Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics study of recombinant hirudin in the plasma of rats using chromogenic substrate, ELISA, and radioisotope assays.
    Jiang SY; Jiao J; Zhang TT; Xu YP
    PLoS One; 2013; 8(6):e64336. PubMed ID: 23785400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of heparin and hirudin on thrombin binding to the normal and the de-endothelialized rabbit aorta in vitro.
    Hatton MW; Moar SL
    Thromb Haemost; 1991 Aug; 66(2):208-12. PubMed ID: 1771613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B; Bergqvist D
    Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.
    Meng M; Liu Y; Wang YB; Wang JC; Zhang H; Wang XQ; Zhang X; Lu WL; Zhang Q
    J Control Release; 2008 Jun; 128(2):113-9. PubMed ID: 18423766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
    Zhang YJ; Wang XL; Wu JM; Cheng MX
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):801-4. PubMed ID: 17639978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fermentation, purification and identification of recombinant RGD-Hirudin].
    Mo W; Zhang YL; Wang LS; Yang XY; Song HY
    Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):126-9. PubMed ID: 16108503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hirudin and hirudin-based peptides.
    Stone SR; Maraganore JM
    Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
    [No Abstract]   [Full Text] [Related]  

  • 36. A new single-injury model of balloon angioplasty in cholesterol-fed rabbits: beneficial effect of hirudin and comparison with double-injury model.
    Barry WL; Wiegman PJ; Gimple LW; Gertz SD; Powers ER; Owens GK; Sarembock IJ
    Lab Invest; 1997 Jul; 77(1):109-16. PubMed ID: 9251684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraocular injection of recombinant hirudin to prevent experimental postoperative fibrin.
    Toth CA; Nasir MA; Ho CL; Mittra RA
    Retina; 1997; 17(4):315-20. PubMed ID: 9279948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine phosphorylation of recombinant hirudin increases affinity to thrombin and antithrombotic activity.
    Volkova A; Semenyuk P
    Proteins; 2024 Mar; 92(3):329-342. PubMed ID: 37860993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of 125I-hirudin in rats and dogs.
    Richter M; Cyranka U; Nowak G; Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):64-9. PubMed ID: 2459034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.